INNOVADERM CRO IS NOW INDERO.

Communication is Key to Unlocking Clinical Trial Success

Laura Tomat

Laura Tomat

Senior Director Clinical and Project Management

Author picture

The importance of clear, consistent communication between contract research organisations (CRO), sponsors and trial sites cannot be stressed enough. Effective collaboration between all contributors to a clinical trial is vital to ensure that differing needs and priorities are accommodated, from designing a project plan and setting milestones to establishing escalation pathways and driving timelines. Laura Tomat, Senior Director Clinical and Project Management at Indero, explores three critical aspects of communication in clinical research; the economics of communication, optimised delivery channels, and personalised communication in this article by Journal for Clinical Studies.

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.